Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2011-04-12
2011-04-12
Noakes, Suzanne M (Department: 1656)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C977S779000, C977S906000, C977S911000
Reexamination Certificate
active
07923536
ABSTRACT:
The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human serum albumin and/or deferoxamine. The human serum albumin is present in an amount effective to reduce one or more side effects associated with administration of the pharmaceutical composition. The invention also provides methods for reducing one or more side effects of administration of the pharmaceutical composition, methods for inhibiting microbial growth and oxidation in the pharmaceutical composition, and methods for enhancing transport and binding of a pharmaceutical agent to a cell.
REFERENCES:
patent: 4425319 (1984-01-01), Yokoyama et al.
patent: 4645660 (1987-02-01), Takahashi et al.
patent: 5272171 (1993-12-01), Ueda et al.
patent: 5362478 (1994-11-01), Desai et al.
patent: 5399363 (1995-03-01), Liversidge et al.
patent: 5439686 (1995-08-01), Desai et al.
patent: 5498421 (1996-03-01), Grinstaff et al.
patent: 5505932 (1996-04-01), Grinstaff et al.
patent: 5508021 (1996-04-01), Grinstaff et al.
patent: 5512268 (1996-04-01), Grinstaff et al.
patent: 5560933 (1996-10-01), Soon-Shiong et al.
patent: 5616330 (1997-04-01), Kaufman et al.
patent: 5626862 (1997-05-01), Brem et al.
patent: 5635207 (1997-06-01), Grinstaff et al.
patent: 5639473 (1997-06-01), Grinstaff et al.
patent: 5650156 (1997-07-01), Grinstaff et al.
patent: 5651986 (1997-07-01), Brem et al.
patent: 5665382 (1997-09-01), Grinstaff et al.
patent: 5665383 (1997-09-01), Grinstaff et al.
patent: 5681846 (1997-10-01), Trissel
patent: 5714520 (1998-02-01), Jones et al.
patent: 5716981 (1998-02-01), Hunter et al.
patent: 5731355 (1998-03-01), Jones et al.
patent: 5731356 (1998-03-01), Jones et al.
patent: 5886026 (1999-03-01), Hunter et al.
patent: 5916596 (1999-06-01), Desai et al.
patent: 5945033 (1999-08-01), Yen
patent: 5977163 (1999-11-01), Li et al.
patent: 5990153 (1999-11-01), Wood et al.
patent: 5994341 (1999-11-01), Hunter et al.
patent: 5997904 (1999-12-01), Magdassi et al.
patent: 6028108 (2000-02-01), George
patent: 6096331 (2000-08-01), Desai et al.
patent: 6100302 (2000-08-01), Pejaver et al.
patent: 6120805 (2000-09-01), Spenlehauer et al.
patent: 6143276 (2000-11-01), Unger
patent: 6147122 (2000-11-01), Mirejovsky et al.
patent: 6150423 (2000-11-01), Carpenter
patent: 6177477 (2001-01-01), George et al.
patent: 6197051 (2001-03-01), Zhong
patent: 6197349 (2001-03-01), Westesen et al.
patent: 6204054 (2001-03-01), Sutton et al.
patent: 6306993 (2001-10-01), Rothbard et al.
patent: 6310039 (2001-10-01), Kratz
patent: 6326406 (2001-12-01), De Tommaso
patent: 6362234 (2002-03-01), Hendler
patent: 6399087 (2002-06-01), Zhang et al.
patent: 6441025 (2002-08-01), Li et al.
patent: 6458373 (2002-10-01), Lambert et al.
patent: 6469069 (2002-10-01), Mirejovsky et al.
patent: 6506405 (2003-01-01), Desai et al.
patent: 6528067 (2003-03-01), Magdassi et al.
patent: 6537579 (2003-03-01), Desai et al.
patent: 6565842 (2003-05-01), Sojomihardo et al.
patent: 6652884 (2003-11-01), Falciani
patent: 6743826 (2004-06-01), Hegedus et al.
patent: 6749868 (2004-06-01), Desai et al.
patent: 6753006 (2004-06-01), Desai et al.
patent: 6759431 (2004-07-01), Hunter et al.
patent: 7119124 (2006-10-01), Hegedus et al.
patent: 7332568 (2008-02-01), Trieu et al.
patent: 7771751 (2010-08-01), Desai et al.
patent: 7820788 (2010-10-01), Desai et al.
patent: 2003/0185894 (2003-10-01), Zenoni et al.
patent: 2003/0187062 (2003-10-01), Zenoni et al.
patent: 2003/0199425 (2003-10-01), Desai et al.
patent: 2005/0004002 (2005-01-01), Desai et al.
patent: 2005/0009731 (2005-01-01), Desai et al.
patent: 2005/0064028 (2005-03-01), Hegedus et al.
patent: 2006/0263434 (2006-11-01), Desai et al.
patent: 2007/0082838 (2007-04-01), De et al.
patent: 2007/0087022 (2007-04-01), Desai et al.
patent: 2007/0092563 (2007-04-01), Desai et al.
patent: 2007/0093547 (2007-04-01), Desai et al.
patent: 2007/0116774 (2007-05-01), Desai et al.
patent: 2007/0117133 (2007-05-01), Trieu et al.
patent: 2007/0117744 (2007-05-01), Desai et al.
patent: 2007/0129448 (2007-06-01), Desai et al.
patent: 2007/0166388 (2007-07-01), Desai et al.
patent: 2008/0063724 (2008-03-01), Desai et al.
patent: 2008/0280987 (2008-11-01), Desai et al.
patent: 2009/0048331 (2009-02-01), Soon-Shiong et al.
patent: 2009/0098210 (2009-04-01), Desai et al.
patent: 2009/0196933 (2009-08-01), De et al.
patent: 2009/0263483 (2009-10-01), Desai et al.
patent: 2009/0304805 (2009-12-01), Desai et al.
patent: 2010/0035800 (2010-02-01), Desai et al.
patent: 2010/0048499 (2010-02-01), Desai et al.
patent: 2010/0112077 (2010-05-01), Desai et al.
patent: 2010/0166869 (2010-07-01), Desai et al.
patent: 2010/0183728 (2010-07-01), Desai et al.
patent: 2010/0215751 (2010-08-01), Desai et al.
patent: 2010/0291673 (2010-11-01), Harper et al.
patent: 2010/0297243 (2010-11-01), Desai et al.
patent: 0 227 593 (1987-07-01), None
patent: 0 544 292 (1993-06-01), None
patent: 0 544 292 (1993-06-01), None
patent: 2 775 900 (1999-09-01), None
patent: 2127606 (1999-03-01), None
patent: WO-92/07259 (1992-04-01), None
patent: WO-94/13300 (1994-06-01), None
patent: WO-94/18954 (1994-09-01), None
patent: WO-94/20072 (1994-09-01), None
patent: WO-95/03036 (1995-02-01), None
patent: WO-96/40829 (1996-12-01), None
patent: WO-97/10850 (1997-03-01), None
patent: WO-98/07410 (1998-02-01), None
patent: WO-98/14174 (1998-04-01), None
patent: WO-98/14175 (1998-04-01), None
patent: WO-99/00113 (1999-01-01), None
patent: WO-99/13914 (1999-03-01), None
patent: WO-99/39696 (1999-08-01), None
patent: WO-00/06152 (2000-02-01), None
patent: WO-00/23117 (2000-04-01), None
patent: WO-00/64437 (2000-11-01), None
patent: WO-00/71079 (2000-11-01), None
patent: WO-00/71079 (2000-11-01), None
patent: WO-01/49268 (2001-07-01), None
patent: WO-01/89522 (2001-11-01), None
patent: WO-02/087545 (2002-11-01), None
patent: WO-03/096944 (2003-11-01), None
patent: WO-2004/007520 (2004-01-01), None
patent: WO-2004/007520 (2004-01-01), None
patent: WO-2004/052401 (2004-06-01), None
patent: WO-2004/052401 (2004-06-01), None
patent: WO-2005/117952 (2005-12-01), None
patent: WO-2005/117952 (2005-12-01), None
patent: WO-2006/034147 (2006-03-01), None
patent: WO-2006/034147 (2006-03-01), None
Altmayer, P. et al. (1995). “Propofol Binding to Human Blood Proteins,”Arzneimittel Forschung Drug Research45(II)(10):1053-1056.
Awada, A. (2002) “New Cytotoxic Agents and Molecular-Targeted Therapies in the Treatment of Metastatic Breast Cancer,”Trends in Experimental and Clinical Medicine12:4-15.
Awada, A. et al. (2003). “The Pipeline of New Anticancer Agents for Breast Cancer Treatment in 2003,”Critical Reviews in Oncology/Hematology48:45-63.
Bayés, M. et al. (May 2003). “Gateways to Clinical Trials,”Methods and Findings in Experimental and Clinical Pharmacology25(4):317-340.
Bielen, S. J. et al. (1996). “The Effect of a Cyclodextrin Vehicle on the Cardiovascular Profile of Propofol in Rats,”Anest. Analg. 82:920-924.
Briggs, L.P. et al. (1982). “An Adverse Reaction to the Administration of Disoprofol (Diprivan),”Anaesthesia37(7):1099-1101.
Calabresi, P. et al. (1996). Introduction of “Chemotherapy of Neoplastic Diseases,” Section X in Goodman and Gilman'sThe Pharmacological Basis of Therapeutics, 9thed., McGraw-Hill: New York, pp. 1225-1230.
Campbell, K. J. et al. (Jul. 2003). “A Phase I Trial of ABI-007 Administered Weekly for Three Doses Every 4 Weeks in Patients With Advanced Non-Hematologic Malignancies,”Proceedings of the American Association for Cancer Researchheld on Jul. 11-14, 2003, Washington Convention Center, Washington, D. C., vol. 44(2ndedition), p. 1059, abstract No. R5337.
Carter, D.C. et al. (1994). “Structures of Serum Albumin,”Advances in Protein Chemistry. Schumaker, V.N., ed., Academic Press, Inc.: San Diego, CA, 45:153-203.
Chuang, V. T. G. et al. (May 2002). “Pharmaceutical Strategies Utilizing Recombinant Human Serum
Desai Neil P.
Soon-Shiong Patrick
Trieu Vuong
Abraxis Bioscience, LLC
Morrison & Foerster / LLP
Noakes Suzanne M
Tsay Marsha M
LandOfFree
Compositions and methods of delivery of pharmacological agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods of delivery of pharmacological agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of delivery of pharmacological agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2695471